MAS Advisors’s AbbVie ABBV Stock Holding History

MAS Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$244K	Buy	+1,052	New	+$214K	0.39%	63
2025 Q2	–	Sell	-1,052	Closed	-$220K	–	69
2025 Q1	$220K	Buy	+1,052	New	+$205K	0.34%	64
2024 Q4	–	Sell	-1,072	Closed	-$212K	–	73
2024 Q3	$212K	Buy	+1,072	New	+$200K	0.45%	69
2022 Q4	–	Sell	-1,596	Closed	-$214K	–	94
2022 Q3	$214K	Sell	1,596 -181	-10%	-$26K	0.14%	82
2022 Q2	$272K	Buy	+1,777	New	+$272K	0.25%	66
2022 Q1	–	Sell	-2,052	Closed	-$279K	–	93
2021 Q4	$279K	Buy	+2,052	New	+$242K	0.2%	78

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

MAS Advisors's ABBV Position: Q3 2025 in Review

MAS Advisors opened a new position in AbbVie (ABBV) in Q3 2025: 1,052 shares worth $244K. The stake represents 0.39% of the portfolio and ranks #63 among its holdings. This is a return to the name: MAS Advisors previously reported a position in ABBV as recently as Q1 2025.

MAS Advisors first reported a position in ABBV in Q4 2021 and has held it in 6 quarters since. The position peaked at $279K in Q4 2021. 3,906 funds tracked by Wall St. Rank hold ABBV as of Q3 2025.

MAS Advisors held 1,052 shares of AbbVie worth $244K as of Q3 2025.
AbbVie was a new MAS Advisors position in Q3 2025.
AbbVie made up 0.39% of MAS Advisors's portfolio in Q3 2025, its #63 holding.
MAS Advisors first reported a position in AbbVie in Q4 2021 and has held it in 6 quarters since.
MAS Advisors's AbbVie position peaked at $279K in Q4 2021.
3,906 funds tracked by Wall St. Rank held AbbVie as of Q3 2025.

Based on MAS Advisors's 13F filing for Q3 2025, filed 28 Oct 2025.